Gilead Sciences Inc

NASDAQ:GILD USA Drug Manufacturers - General
Market Cap
$179.15 Billion
Market Cap Rank
#87 Global
#71 in USA
Share Price
$144.40
Change (1 day)
-0.56%
52-Week Range
$96.91 - $155.80
All Time High
$155.80
About

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the t… Read more

Gilead Sciences Inc (GILD) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2025: 0.147x

Based on the latest financial reports, Gilead Sciences Inc (GILD) has a cash flow conversion efficiency ratio of 0.147x as of December 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.33 Billion) by net assets ($22.62 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Gilead Sciences Inc - Cash Flow Conversion Efficiency Trend (1990–2024)

This chart illustrates how Gilead Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Gilead Sciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gilead Sciences Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Gilead Sciences Inc (1990–2024)

The table below shows the annual cash flow conversion efficiency of Gilead Sciences Inc from 1990 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $19.25 Billion $10.83 Billion 0.563x +59.87%
2023-12-31 $22.75 Billion $8.01 Billion 0.352x -17.72%
2022-12-31 $21.21 Billion $9.07 Billion 0.428x -20.85%
2021-12-31 $21.06 Billion $11.38 Billion 0.540x +20.56%
2020-12-31 $18.22 Billion $8.17 Billion 0.448x +11.04%
2019-12-31 $22.65 Billion $9.14 Billion 0.404x +3.49%
2018-12-31 $21.53 Billion $8.40 Billion 0.390x -32.79%
2017-12-31 $20.50 Billion $11.90 Billion 0.580x -34.08%
2016-12-31 $19.36 Billion $17.05 Billion 0.880x -20.81%
2015-12-31 $19.11 Billion $21.25 Billion 1.112x +37.21%
2014-12-31 $15.82 Billion $12.82 Billion 0.810x +206.50%
2013-12-31 $11.74 Billion $3.10 Billion 0.264x -21.03%
2012-12-31 $9.54 Billion $3.19 Billion 0.335x -36.82%
2011-12-31 $6.87 Billion $3.64 Billion 0.530x +14.47%
2010-12-31 $6.12 Billion $2.83 Billion 0.463x -2.23%
2009-12-31 $6.51 Billion $3.08 Billion 0.473x -1.35%
2008-12-31 $4.47 Billion $2.14 Billion 0.480x -2.11%
2007-12-31 $3.60 Billion $1.77 Billion 0.490x -24.77%
2006-12-31 $1.87 Billion $1.22 Billion 0.652x +179.67%
2005-12-31 $3.03 Billion $705.64 Million 0.233x -14.16%
2004-12-31 $1.87 Billion $507.96 Million 0.272x +16.07%
2003-12-31 $1.00 Billion $234.61 Million 0.234x +79.61%
2002-12-31 $571.34 Million $74.41 Million 0.130x +146.40%
2001-12-31 $452.44 Million $-126.98 Million -0.281x -157.96%
2000-12-31 $351.12 Million $-38.20 Million -0.109x +48.33%
1999-12-31 $297.29 Million $-62.60 Million -0.211x -36.97%
1998-12-31 $333.70 Million $-51.30 Million -0.154x +10.50%
1997-12-31 $317.30 Million $-54.50 Million -0.172x -203.65%
1996-12-31 $291.70 Million $-16.50 Million -0.057x +62.74%
1995-12-31 $151.50 Million $-23.00 Million -0.152x +52.29%
1994-12-31 $86.10 Million $-27.40 Million -0.318x -63.81%
1993-12-31 $115.30 Million $-22.40 Million -0.194x -204.29%
1992-12-31 $139.40 Million $-8.90 Million -0.064x -82.22%
1991-12-31 $105.60 Million $-3.70 Million -0.035x +85.11%
1990-12-31 $10.20 Million $-2.40 Million -0.235x --